28 min agoExpert explains why he'd take the Johnson & Johnson vaccineFrom CNN's Adrienne VogtDr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, said that he is eager to review all of the data from Johnson & Johnson’s vaccine. “Were it me, were I not able to get the mRNA vaccine and I only had the choice of Johnson & Johnson vaccine, I would take it assuming that the data look good as we look at the FDA. Janssen is the vaccine arm of Johnson & Johnson. Michael Ciaglo/Getty Images Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech prepares a dose of the Johnson & Johnson COVID-19 vaccine for a clinical trial on December 15, 2020 in Aurora, Colorado. Experts say the Johnson & Johnson vaccine, developed by its vaccine arm Janssen, will still be useful against the pandemic in the United States and around the world, even if the single-dose vaccine doesn’t become the first choice for many.

Source: The Nation January 29, 2021 15:00 UTC